AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimtino M 2mg/1000mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Biovensia Pharmaceutical

Salt Composition

Glimepiride (2mg) + Metformin (1000mg)

Overview Glimtino M 2mg/1000mg Tablet SR

Diabetam SR 2mg/1000mg tablets are classified as antidiabetic medications, combining two active ingredients to manage type 2 diabetes in adults. This formulation helps regulate blood glucose levels. Diabetam SR should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continue taking this medication as prescribed, even if feeling well or achieving target blood sugar levels. Discontinuing treatment without medical consultation risks elevated blood glucose, potentially leading to kidney complications, vision loss, neuropathy, and limb damage. Remember, this medication is one component of a comprehensive diabetes management plan including diet, exercise, and weight control as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect. Learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to treat them promptly. Maintaining regular meals and carrying a fast-acting glucose source is crucial. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional side effects may include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain is also a possibility. This medication is contraindicated for individuals with type 1 diabetes, diabetic ketoacidosis, or severe renal or hepatic impairment. Prior heart disease should be disclosed to your doctor before initiating treatment. Pregnant or breastfeeding individuals require medical consultation before use. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are recommended.

Uses of Glimtino M 2mg/1000mg Tablet SR

Managing type 2 diabetes

Major Benefits of Glimtino M 2mg/1000mg Tablet SR:

Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the Glimtino M 2mg/1000mg Tablet SR whole; avoid chewing, crushing, or fracturing. Consume with a meal.

Common Side effects of Glimtino M 2mg/1000mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimtino M 2mg/1000mg Tablet SR:

Administer this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the Glimtino M 2mg/1000mg Tablet SR whole; avoid chewing, crushing, or fracturing. Consume this extended-release tablet with a meal.

How Glimtino M 2mg/1000mg Tablet SR works:

Glimtino M 2mg/1000mg Extended-Release tablets contain glimepiride and metformin, two anti-diabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose uptake, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimtino M 2mg/1000mg SR tablets with alcohol is strongly discouraged due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimtino M 2mg/1000mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Physician consultation is advised.

Breast feedingBreast feedingUNSAFE

Extended-release Glimtino M 2mg/1000mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Impaired driving is possible with both hypo- and hyperglycemia. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Glimtino M 2mg/1000mg SR tablets, potentially requiring dosage modification. Consult your physician for guidance. Glimtino M 2mg/1000mg SR tablets are contraindicated in individuals with severe kidney disease. Routine monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Exercise caution when prescribing Glimtino M 2mg/1000mg Tablet SR to individuals with hepatic impairment. Dosage modification of Glimtino M 2mg/1000mg Tablet SR may be necessary. Physician consultation is advised. For patients exhibiting mild to moderate liver dysfunction, initiate Glimtino M 2mg/1000mg Tablet SR therapy with a reduced starting dose; its use is contraindicated in those with severe liver disease.

What if you forget to take Glimtino M 2mg/1000mg Tablet SR :

Should you forget a Glimtino M 2mg/1000mg SR tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimtino M 2mg/1000mg Tablet SR

LabelValue
Potential for Dependence None.
Type of Medication Medication for diabetes

FAQs on Glimtino M 2mg/1000mg Tablet SR

Maintain this medication within its original, securely sealed container. Follow the storage guidelines provided on the packaging. Discard any remaining medication. Prevent access by children, pets, and other individuals.
Glimtino M 2mg/1000mg Tablet SR carries a risk of lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. This complication, also termed Metformin-associated lactic acidosis (MALA), is uncommon but poses a significant threat to individuals with pre-existing kidney impairment, the elderly, or those who consume substantial alcohol. Symptoms such as muscle aches, weakness, vertigo, fatigue, cold extremities, dyspnea, nausea, emesis, abdominal discomfort, and bradycardia may indicate lactic acidosis. Should these symptoms develop, discontinue Glimtino M 2mg/1000mg Tablet SR and seek immediate medical attention.
Glimtino M 2mg/1000mg Extended-Release tablets contain glimepiride and metformin, two medications used together to manage type 2 diabetes. In adults, this combination therapy, coupled with a healthy diet and regular physical activity, helps regulate blood sugar. Glimepiride stimulates the pancreas to release more insulin, thus reducing blood glucose. Metformin acts by decreasing hepatic glucose production and enhancing insulin responsiveness. This formulation is unsuitable for managing type 1 diabetes.
Glimtino M 2mg/1000mg SR tablets may cause frequent side effects including low blood sugar (hypoglycemia), taste disturbances, nausea, abdominal pain, diarrhea, and headaches. Rare but potentially serious adverse events such as lactic acidosis may occur. Prolonged treatment may result in vitamin B12 deficiency.
Prolonged use of Glimtino M 2mg/1000mg Tablet SR can indeed lead to Vitamin B12 deficiency. This medication hinders the absorption of Vitamin B12 within the gastrointestinal tract. Untreated deficiency may result in anemia, neurological complications such as paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive impairment, and ataxia. Preventive measures, according to some studies, include supplemental Vitamin B12 at least annually.
Indeed, Glimtino M 2mg/1000mg SR tablets may induce hypoglycemia. Low blood sugar manifests as nausea, headache, irritability, hunger pangs, sweating, lightheadedness, tachycardia, and feelings of anxiety or tremor. This risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carrying a readily available fast-acting sugar source, such as glucose tablets, honey, or fruit juice, is advisable.
Combining Glimtino M 2mg/1000mg SR tablets and alcohol is unsafe. Concurrent use may cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glimtino M 2mg/1000mg Tab...
53
MRP 65
18% off